All stock lists
Pricesmart Inc (NASDAQ:PSMT)
US · Delayed Price · Currency is USD
Consumer Defensive · Discount Stores
172.85+1.90 (+1.11%)
Market cap
$5.33B
Health Score
Analyst consensus
Listed since
Sep 2, 1997
Website
Insider Score
––Not scored
PSMT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Financial Health Score
Sound
From PSMT’s reported statements · Q2 2026 (trailing 12 months)
Profitability11 / 20
Profitable, but on a thin margin.
- Revenue
- $5.69B
- Net income
- $158.4M
- Net margin
- 2.8%
Leverage18 / 20
Little or no net debt.
- Total debt
- $325.5M
- Cash
- $208.4M
- Net debt / EBITDA
- 0.34x
Liquidity9 / 20
Covers near-term obligations, without much room.
- Current assets
- $1.06B
- Current liabilities
- $879.0M
- Current ratio
- 1.21
Cash generation12 / 20
Roughly cash-neutral.
- Operating cash flow
- $274.4M
- Free cash flow
- $73.7M
- FCF margin
- 1.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 30.2M
- Share growth (1y)
- 0.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PSMT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 |
| Revenue | 1.48 B | 1.50 B | 1.38 B | 1.33 B | 1.32 B | 1.36 B |
| Revenue Growth (YoY) | 12.49 % | 9.65 % | 9.92 % | 8.56 % | 7.15 % | 5.57 % |
| Cost of Revenue | 1.22 B | 1.23 B | 1.14 B | 1.10 B | 1.09 B | 1.13 B |
| Gross Profit | 262.22 M | 265.07 M | 244.38 M | 231.91 M | 229.65 M | 233.75 M |
| SG&A Expense | 195.71 M | 189.21 M | 181.12 M | 177.77 M | 172.81 M | 167.27 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 196.58 M | 189.21 M | 181.12 M | 177.77 M | 172.81 M | 167.27 M |
| Operating Income | 65.64 M | 75.87 M | 63.26 M | 54.15 M | 56.84 M | 66.48 M |
| Pretax Income | 55.14 M | 66.69 M | 55.70 M | 46.36 M | 49.08 M | 60.14 M |
| Tax Provision | 15.45 M | 17.60 M | 15.53 M | 14.82 M | 13.92 M | 16.38 M |
| Net Income | 39.69 M | 49.09 M | 38.94 M | 30.69 M | 34.20 M | 43.60 M |
| EPS (Basic) | 1.28 | 1.62 | 1.29 | 1.02 | 1.14 | 1.45 |
| EPS (Diluted) | 1.28 | 1.62 | 1.29 | 1.02 | 1.14 | 1.45 |
| Shares Outstanding | 30.24 M | 30.23 M | 30.17 M | 30.07 M | 30.07 M | 30.06 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.